Hear the case for including psilocybin therapy as a care option for those with serious illness during this special roundtable. Leaders share the latest research on the efficacy of psilocybin therapy for treatment-resistant depression and depression in cancer. Discussion highlights how the inclusion of a psilocybin therapy option may impact care decision-making and planning, and improve outcomes, such as patient quality of life. Together, we explore the optimal public policy routes for integrating this intervention into care for those with serious illness.
Speakers:
Gary Bacher, Chief Officer for Strategy, Policy, and Legal Affairs at Capital Caring Health,
Steve Levine, MD, VP of Patient Access, COMPASS Pathways,
Manish Agrawal, MD, Cancer Center Director, Aquilino Cancer Center and CEO Sunstone Therapies
Moderator:
Patrick T. Courneya, MD, Chief Health Plan Medical Officer, HealthPartners
